Enjoy complimentary customisation on priority with our Enterprise License!
Conjunctivitis may occur due to allergies and involves the infection of the eye in which the conjunctiva is infected. The patent expiries of few drugs such as Lotemax, Patanol, Pataday, and Lastacaft along with the expected entry of few other drugs into the market during the forecast period are envisaged to result in this market’s slow growth rate of approximately 2% by 2019.
The unmet need for viral conjunctivitis is the key driver for the growth of this market. Since there are no approved drugs for the treatment of viral conjunctivitis, many companies and researchers are now developing drugs that are in the clinical stage of development. These drugs are expected to aid in the treatment of viral conjunctivitis and their effectiveness will, in turn, promote growth in this market in the next four years.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Overview: Conjunctivitis
PART 06: Pipeline analysis
PART 07: Market landscape
PART 08: Market segmentation based on condition type
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Key vendor analysis
PART 17: Appendix
PART 18: Explore Technavio
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.